168 related articles for article (PubMed ID: 10603936)
1. Phospholamban ablation and compensatory responses in the mammalian heart.
Chu G; Ferguson DG; Edes I; Kiss E; Sato Y; Kranias EG
Ann N Y Acad Sci; 1998 Sep; 853():49-62. PubMed ID: 10603936
[TBL] [Abstract][Full Text] [Related]
2. Compensatory mechanisms associated with the hyperdynamic function of phospholamban-deficient mouse hearts.
Chu G; Luo W; Slack JP; Tilgmann C; Sweet WE; Spindler M; Saupe KW; Boivin GP; Moravec CS; Matlib MA; Grupp IL; Ingwall JS; Kranias EG
Circ Res; 1996 Dec; 79(6):1064-76. PubMed ID: 8943945
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of endogenous adenosine alter metabolism and enhance reduction in contractile function during low-flow ischemia: associated changes in expression of Ca(2+)-ATPase and phospholamban.
Sommerschild HT; Lunde PK; Deindl E; Jynge P; Ilebekk A; Kirkebøen KA
J Mol Cell Cardiol; 1999 Oct; 31(10):1897-911. PubMed ID: 10525427
[TBL] [Abstract][Full Text] [Related]
4. Gender differences in the modulation of cardiac gene expression by dietary conjugated linoleic acid isomers.
Tappia PS; Dent MR; Aroutiounova N; Babick AP; Weiler H
Can J Physiol Pharmacol; 2007; 85(3-4):465-75. PubMed ID: 17612656
[TBL] [Abstract][Full Text] [Related]
5. Role of cardiac renin-angiotensin system in sarcoplasmic reticulum function and gene expression in the ischemic-reperfused heart.
Takeo S; Nasa Y; Tanonaka K; Yamaguchi F; Yabe K; Hayashi H; Dhalla NS
Mol Cell Biochem; 2000 Sep; 212(1-2):227-35. PubMed ID: 11108155
[TBL] [Abstract][Full Text] [Related]
6. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.
Luo W; Grupp IL; Harrer J; Ponniah S; Grupp G; Duffy JJ; Doetschman T; Kranias EG
Circ Res; 1994 Sep; 75(3):401-9. PubMed ID: 8062415
[TBL] [Abstract][Full Text] [Related]
7. Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation.
Sato Y; Kiriazis H; Yatani A; Schmidt AG; Hahn H; Ferguson DG; Sako H; Mitarai S; Honda R; Mesnard-Rouiller L; Frank KF; Beyermann B; Wu G; Fujimori K; Dorn GW; Kranias EG
J Biol Chem; 2001 Mar; 276(12):9392-9. PubMed ID: 11115498
[TBL] [Abstract][Full Text] [Related]
8. The relative phospholamban and SERCA2 ratio: a critical determinant of myocardial contractility.
Koss KL; Grupp IL; Kranias EG
Basic Res Cardiol; 1997; 92 Suppl 1():17-24. PubMed ID: 9202840
[TBL] [Abstract][Full Text] [Related]
9. Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts.
Kiss E; Brittsan AG; Edes I; Grupp IL; Grupp G; Kranias EG
Circ Res; 1998 Sep; 83(6):608-13. PubMed ID: 9742056
[TBL] [Abstract][Full Text] [Related]
10. Sarcoplasmic reticulum proteins in heart failure.
Lehnart SE; Schillinger W; Pieske B; Prestle J; Just H; Hasenfuss G
Ann N Y Acad Sci; 1998 Sep; 853():220-30. PubMed ID: 10603950
[TBL] [Abstract][Full Text] [Related]
11. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.
Kadambi VJ; Ponniah S; Harrer JM; Hoit BD; Dorn GW; Walsh RA; Kranias EG
J Clin Invest; 1996 Jan; 97(2):533-9. PubMed ID: 8567978
[TBL] [Abstract][Full Text] [Related]
12. Combined phospholamban ablation and SERCA1a overexpression result in a new hyperdynamic cardiac state.
Zhao W; Frank KF; Chu G; Gerst MJ; Schmidt AG; Ji Y; Periasamy M; Kranias EG
Cardiovasc Res; 2003 Jan; 57(1):71-81. PubMed ID: 12504816
[TBL] [Abstract][Full Text] [Related]
13. Functional properties of transgenic mouse hearts overexpressing both calsequestrin and the Na(+)-Ca(2+) exchanger.
Linck B; Bokník P; Huke S; Kirchhefer U; Knapp J; Lüss H; Müller FU; Neumann J; Tanriseven Z; Vahlensieck U; Baba HA; Jones LR; Philipson KD; Schmitz W
J Pharmacol Exp Ther; 2000 Aug; 294(2):648-57. PubMed ID: 10900244
[TBL] [Abstract][Full Text] [Related]
14. Phospholamban gene dosage effects in the mammalian heart.
Luo W; Wolska BM; Grupp IL; Harrer JM; Haghighi K; Ferguson DG; Slack JP; Grupp G; Doetschman T; Solaro RJ; Kranias EG
Circ Res; 1996 May; 78(5):839-47. PubMed ID: 8620604
[TBL] [Abstract][Full Text] [Related]
15. Regulatory role of phospholamban in the efficiency of cardiac sarcoplasmic reticulum Ca2+ transport.
Frank K; Tilgmann C; Shannon TR; Bers DM; Kranias EG
Biochemistry; 2000 Nov; 39(46):14176-82. PubMed ID: 11087366
[TBL] [Abstract][Full Text] [Related]
16. beta-Adrenergic regulation of cAMP and protein phosphorylation in phospholamban-knockout mouse hearts.
Kiss E; Edes I; Sato Y; Luo W; Liggett SB; Kranias EG
Am J Physiol; 1997 Feb; 272(2 Pt 2):H785-90. PubMed ID: 9124439
[TBL] [Abstract][Full Text] [Related]
17. Alterations in expression of sarcoplasmic reticulum gene in Dahl rats during the transition from compensatory myocardial hypertrophy to heart failure.
Okayama H; Hamada M; Kawakami H; Ikeda S; Hashida H; Shigematsu Y; Hiwada K
J Hypertens; 1997 Dec; 15(12 Pt 2):1767-74. PubMed ID: 9488237
[TBL] [Abstract][Full Text] [Related]
18. Coordinate regulation of SR Ca(2+)-ATPase and phospholamban expression in developing murine heart.
Harrer JM; Haghighi K; Kim HW; Ferguson DG; Kranias EG
Am J Physiol; 1997 Jan; 272(1 Pt 2):H57-66. PubMed ID: 9038922
[TBL] [Abstract][Full Text] [Related]
19. Sarcoplasmic reticulum Ca2+ refilling controls recovery from Ca2+-induced Ca2+ release refractoriness in heart muscle.
Szentesi P; Pignier C; Egger M; Kranias EG; Niggli E
Circ Res; 2004 Oct; 95(8):807-13. PubMed ID: 15388639
[TBL] [Abstract][Full Text] [Related]
20. Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility.
Neumann J; Boknik P; DePaoli-Roach AA; Field LJ; Rockman HA; Kobayashi YM; Kelley JS; Jones LR
J Mol Cell Cardiol; 1998 Oct; 30(10):1991-2002. PubMed ID: 9799653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
